Lista de obras -

A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers

artículo científico publicado en 2012

Abnormal Cardiac Strain in Children and Young Adults with HIV Acquired in Early Life ⬇️

artículo científico publicado el 26 de abril de 2012

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

artículo científico publicado en 2016

Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.

artículo científico publicado en 2014

Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort study

artículo científico publicado en 2017

Bone mineral density in children and adolescents with perinatal HIV infection

artículo científico publicado en 2013

CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption ⬇️

artículo científico publicado el 1 de julio de 2011

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States

artículo científico publicado en 2015

Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study

artículo científico publicado en 2013

Characteristics of HIV Infected Adolescents in Latin America: Results from the NISDI Pediatric Study ⬇️

artículo científico publicado el 4 de agosto de 2010

Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study ⬇️

artículo científico publicado el 15 de agosto de 2011

Combination antiretroviral use and preterm birth

artículo científico publicado en 2012

Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy

artículo científico publicado en 2015

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants

artículo científico publicado en 2015

Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.

artículo científico publicado en 2010

Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium

artículo científico publicado en 2013

Dyslipidemia in a Cohort of HIV-infected Latin American Children Receiving Highly Active Antiretroviral Therapy ⬇️

artículo científico publicado el 1 de octubre de 2010

Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy

artículo científico publicado en 2009

Early viral suppression improves neurocognitive outcomes in HIV-infected children

artículo científico publicado en 2015

Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy

artículo científico publicado en 2012

Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue

artículo científico publicado en 2007

Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study

artículo científico publicado en 2016

Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children

artículo científico publicado en 2016

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

artículo científico publicado en 2009

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children ⬇️

artículo científico publicado el 1 de enero de 2010

High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.

artículo científico publicado en 2011

Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries

artículo científico publicado en 2015

In Uteroand Postnatal Exposure to Antiretrovirals Among HIV-Exposed But Uninfected Children in the United States ⬇️

artículo científico publicado el 10 de junio de 2011

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents

artículo científico publicado en 2015

Increased coronary vessel wall thickness in HIV-infected young adults

artículo científico publicado en 2014

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy ⬇️

artículo científico publicado el 13 de marzo de 2011

Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood

artículo científico publicado en 2010

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

artículo científico publicado en 2015

Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children

artículo científico publicado en 2015

Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure ⬇️

artículo científico publicado el 1 de diciembre de 2011

Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean

artículo científico publicado en 2016

Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States

artículo científico publicado en 2011

Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults

artículo científico publicado en 2015

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

artículo científico publicado en 2013

Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium

artículo científico publicado en 2020

Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America

artículo científico publicado en 2015

Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

artículo científico publicado en 2010

Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.

artículo científico publicado en 2014

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

artículo científico publicado en 2012

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093

artículo científico publicado en 2015

Sexual Risk Behavior Among Youth With Perinatal HIV Infection in the United States: Predictors and Implications for Intervention Development ⬇️

artículo científico publicado el 7 de noviembre de 2012

Short communication: kidney dysfunction among HIV-infected children in Latin America and the Caribbean

artículo científico publicado en 2014

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children

artículo científico publicado en 2004

Steady-State Pharmacokinetics of Tenofovir-Based Regimens in HIV-Infected Pediatric Patients ⬇️

artículo científico publicado el 13 de junio de 2011

The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.

artículo científico publicado en 2016

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs

artículo científico publicado en 2016

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

artículo científico publicado en 2018

Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value

artículo científico publicado en 2010

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial

artículo científico publicado en 2012

Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate

artículo científico publicado en 2014

Lista de obras de

A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers

Abnormal Cardiac Strain in Children and Young Adults with HIV Acquired in Early Life ⬇️

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.

Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort study

Bone mineral density in children and adolescents with perinatal HIV infection

CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption ⬇️

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States

Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study

Characteristics of HIV Infected Adolescents in Latin America: Results from the NISDI Pediatric Study ⬇️

Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study ⬇️

Combination antiretroviral use and preterm birth

Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants

Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.

Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium

Dyslipidemia in a Cohort of HIV-infected Latin American Children Receiving Highly Active Antiretroviral Therapy ⬇️

Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy

Early viral suppression improves neurocognitive outcomes in HIV-infected children

Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy

Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue

Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study

Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children ⬇️

High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.

Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries

In Uteroand Postnatal Exposure to Antiretrovirals Among HIV-Exposed But Uninfected Children in the United States ⬇️

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents

Increased coronary vessel wall thickness in HIV-infected young adults

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy ⬇️

Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children

Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure ⬇️

Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean

Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States

Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium

Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America

Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093

Sexual Risk Behavior Among Youth With Perinatal HIV Infection in the United States: Predictors and Implications for Intervention Development ⬇️

Short communication: kidney dysfunction among HIV-infected children in Latin America and the Caribbean

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children

Steady-State Pharmacokinetics of Tenofovir-Based Regimens in HIV-Infected Pediatric Patients ⬇️

The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial

Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate